Healthcare DIVE June 13, 2019
Kristin Jensen

Dive Brief:

  • IBM, Walmart, KPMG and Merck & Co. said the U.S. Food and Drug Administration chose them to be part of a blockchain pilot program designed to track and ensure the integrity of prescription medicines and vaccines.
  • The companies said they expect to complete the program in the fourth quarter of this year, with results slated for publication in an FDA report.
  • Participants “will evaluate next steps” after the conclusion of the pilot, the companies said in a joint statement Thursday.
Dive Insight:

The four industry powerhouses are the latest to tackle the need for an interoperable system that can track and trace medications across the supply...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, FDA, Govt Agencies, Technology
A Pro-Crypto President: What Trump 2.0 Holds for Blockchain’s Future
Blockchain in Healthcare: A Necessary Innovation or a Misguided Panacea?
Rumors Of Blockchain's Demise Have Been Greatly Exaggerated
Solving Data Congestion In Decentralized Blockchain Networks
Your VPN May Not Be Private. This Blockchain Startup Nym Has A Fix

Share This Article